Rev Group Put Options Active as Stock Sells Off

REVG fell to a record low in today's trading after an earnings miss

by Elizabeth Harrow

Published on Sep 6, 2018 at 2:12 PM

Rev Group Inc (NYSE: REVG) has tanked 11.8% to $13.89 in today's trading, after the company reported an adjusted fiscal third-quarter profit of 38 cents per share on revenue of $597.7 million -- well below Wall Street's forecast for earnings of 44 cents per share on $649.6 million in sales. REVG also lowered its full-year revenue guidance to a range between $2.4 billion and $2.5 billion, just shy of the consensus estimate of $2.51 billion, "primarily due to continued chassis availability issues and impact of longer material lead times."

The stock's post-earnings sell-off -- and the resulting short-sale restriction -- has sparked unusually heavy options volume on REVG, which typically doesn't garner much attention from speculative players. So far, 1,205 puts and 261 calls have changed hands, which represents about nine times the expected intraday volume. In fact, today's put activity has already set a new 52-week high.

The most active strike is REVG's September 17.50 put, where 1,021 contracts have been exchanged -- accounting for nearly all of today's put volume. Trade-Alert data shows that most of the 1,030 contracts in open interest at this strike were added last Tuesday, Aug. 28. At the time of initiation, REVG was trading around $17.17, and the puts closed at $1.45.

In today's session, where the stock fell to a new record low of $12.72 earlier, those September 17.50 puts have crossed the tape at a volume-weighted average price (VWAP) of $3.33.

a schaeffer's exclusive


5 tips to leverage profits in this FREE insider report!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

The Trend Minting Millionaires -- But Who Is Really Paying?
Porter Stansberry is making a concerning prediction.
Wall Street Reacts to Fed Decision, Trade Deal
Investors waited and reacted to the Fed decision and trade headlines
Sarepta Therapeutics Stock Eyes Best Day in 3 Years on FDA Reversal
SRPT is buzzing on the FDA's change of heart
The Trend Minting Millionaires -- But Who Is Really Paying?
Porter Stansberry is making a concerning prediction.